| Klebsiella pneumoniae causes a wide variety of infectious diseases. Lipopolysaccharide (LPS) is a large heat-stable polymer that is gram-negative bacteria's major outer membrane component, accounting for roughly 75% of the surface area and 5-10% of the total dry weight. Therefore the current in vivo study was carried out to investigate the immunomodulatory effect of purified lipopolysaccharide produced from local clinical Klebsiella pneumoniae isolates compared with ZnO-NPs and LPS-ZnO NPs. To do the experimental evaluations 35, Balb/c mouse was injected intramuscularly (i.m.) with different concentrations of the purified LPS, ZnoNPs and LPS-ZnoNPs for 12 days and immunized with 10% SRBCs (i.p) on day 4 and 8 of the schedule, while K. pneumoniae suspension and normal saline for positive and negative control groups. Focus on estimating body weight before and after treatment, Arthus and delayed-type hypersensitivity, and detecting serum level of cytokines (TLR-2, IL1Beta, IL4, and IL10) using sandwich ELISA. The data showed the highest value before and after treatment with LPS-ZnO NPs recorded in 2µg/mouse was 27. 92±1.48 and 31.50±0.4, respectively. In Arthurs reaction and Delayed type hypersensitivity, the highest results showed in the positive control group injected with K. pneumoniae 4.08±0.17 and 4.86±80.02, respectively. The results of TLR-2 showed the highest value in the positive control group, 242.17±3.98 pg/ml, followed by Group LPS at 135.51.58 pg/ml. The results of Interleukin-1Beta showed the highest value in the positive control group, 254.88±3.51 pg/ml, followed by Group LPS 174.3± 1.46 pg/ml. The concentration of IL-4 in serum of treated albino mice showed the highest value in the positive control group, 136.2±1.12 pg/ml, followed by Group LPS 86.12±1.49 pg/ml. While the highest value of IL-10 was recorded in the positive control group, 98.58± 4.09 pg/ml, followed by Group LPS- ZnoNP in concentration 4µg/ mouse was 86.018±0.69 pg/ml. The results of the statistical analysis showed a significant difference (P≤0.05) between LPS, ZnoNPs, and LPs-ZnoNPs treated groups and control groups (positive & negative). In the present study, we can conclude that LPS-ZnO NPs had a positive immunomodulatory effect on immune response in immunized mice. As shown in the results of the level of IL-1 beta, IL-4, IL-10, and TLRs-2, Abs titer, and Arthus and DTH reactions. |
- Sharma S, Mudgal N, Sharma P, Shrngi B. Comparison of phenotypic characteristics and virulence traits of Klebsiella pneumoniae obtained from pneumonic and healthy camels (Camelus dromedarius). Adv Anim Vet Sci. 2015;3(2):116-22.
- Yu W-L, Chuang YC, Calderwood SB. Microbiology and pathogenesis of Klebsiella pneumoniae infection. UpToDate: UpToDate, Waltham, MA. 2008.
- Tan Y, Kagan JC. A cross-disciplinary perspective on the innate immune responses to bacterial lipopolysaccharide. Mol Cell. 2014;54(2):212-23.
- Ju-Nam Y, Lead JR. Manufactured nanoparticles: an overview of their chemistry, interactions and potential environmental implications. Sci Total Environ. 2008;400(1-3):396-414.
- Madhumitha G, Elango G, Roopan SM. Biotechnological aspects of ZnO nanoparticles: overview on synthesis and its applications. Appl Microbiol Biotechnol. 2016;100(2):571-81.
- Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta (BBA)-Molecular Cell Res. 2014;1843(11):2563-82.
- Gibson MS, Kaiser P, Fife M. The chicken IL-1 family: evolution in the context of the studied vertebrate lineage. Immunogenetics. 2014;66(7):427-38.
- Reinhart R, Kaufmann T. IL-4 enhances survival of in vitro-differentiated mouse basophils through transcription-independent signaling downstream of PI3K. Cell Death Dis. 2018;9(7):1-12.
- Mingomataj EC, Bakiri AH. Regulator versus effector paradigm: interleukin-10 as indicator of the switching response. Clin Rev Allergy Immunol. 2016;50(1):97-113.
- Bagheri V, Askari A, Arababadi MK, Kennedy D. Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection? Hum Immunol. 2014;75(6):549-54.
- Galanos C, Lüderitz O, Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem. 1969;9(2):245-9.
- SH R, Mohammad S, Sameer E. A partially purified lipopolysaccharide extracted from klebsiella pneumonia as antibacterial. Extraction.52:36.1.
- Li Y, Shi Z, Radauer-Preiml I, Andosch A, Casals E, Luetz-Meindl U, et al. Bacterial endotoxin (lipopolysaccharide) binds to the surface of gold nanoparticles, interferes with biocorona formation and induces human monocyte inflammatory activation. Nanotoxicology. 2017;11(9-10):1157-75.
- Tansho S, Abe S, Mizutani S, Ono Y, Takesako K, Yamaguchi H. Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen. Microbiol Immunol. 2002;46(5):307-11.
- Levinson W. Review of medical microbiology and immunology: McGraw-Hill Education; 2014.
- ZayedP NA. Effect of ZnO NPs on body and organ weights in male rats. IJISET. 2018;5(8):12-25.
- Meier R, Bein H, Jaques R. The action of bacterial polysaccharides on allergic phenomena. Int Arch Allergy Immunol. 1957;11(1-2):101-18.
- Matsui M, Rouleau V, Bruyère-Ostells L, Goarant C. Gene expression profiles of immune mediators and histopathological findings in animal models of leptospirosis: comparison between susceptible hamsters and resistant mice. Infect Immun. 2011;79(11):4480-92.
- Chen X, Xie X, Wu D, Zhang S, Zhang W, Cao Y. The pre-activated immune response induced by LPS protects host from leptospirosis. Plos One. 2020;15(11):e0242742.
- Santecchia I, Vernel-Pauillac F, Rasid O, Quintin J, Gomes-Solecki M, Boneca IG, et al. Innate immune memory through TLR2 and NOD2 contributes to the control of Leptospira interrogans infection. PLoS Pathog. 2019;15(5):e1007811.
- Cagliero J, Villanueva SY, Matsui M. Leptospirosis pathophysiology: into the storm of cytokines. Front Cell Infect Microbiol. 2018;8:204.
- Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117(14):3720-32.
- Murphy K, Weaver C. Janeway's immunobiology: Garland science; 2016.
- Olejnik M, Kersting M, Rosenkranz N, Loza K, Breisch M, Rostek A, et al. Cell-biological effects of zinc oxide spheres and rods from the nano-to the microscale at sub-toxic levels. Cell Biol Toxicol. 2021;37(4):573-93.
- Shirley M. Dupilumab: first global approval. Drugs. 2017;77(10):1115-21.
- Kamanaka M, Kim ST, Wan YY, Sutterwala FS, Lara-Tejero M, Galán JE, et al. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity. 2006;25(6):941-52.
- Hanley C, Thurber A, Hanna C, Punnoose A, Zhang J, Wingett DG. The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res Lett. 2009;4(12):1409-20.
- Jang B, Xu L, Moorthy MS, Zhang W, Zeng L, Kang M, et al. Lipopolysaccharide-coated CuS nanoparticles promoted anti-cancer and anti-metastatic effect by immuno-photothermal therapy. Oncotarget. 2017;8(62):105584.
|
